HomeInsightsMarket Capitalization

Market Capitalization of Bal Pharma Ltd

Market Capitalization of Bal Pharma Ltd

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

6.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Bal Pharma Ltd

NSE: BALPHARMA

Market Cap

₹ 216.36 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Bal Pharma Ltd is ₹ 216.36 crore as of 22 Nov 24 .
  • The Market Cap of Bal Pharma Ltd changed from ₹ 99.92 crore on March 2019 to ₹ 144.21 crore on March 2024 . This represents a CAGR of 6.31% over 6 years.
  • The Latest Trading Price of Bal Pharma Ltd is ₹ 135.9 as of 22 Nov 15:30 .
  • The dividend payouts of Bal Pharma Ltd changed from ₹ 1 to ₹ 1.2 over 6 quarters. This represents a CAGR of 12.92% .

Historical Market Cap of Bal Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Bal Pharma Ltd

No data available

Image

Bal Pharma Ltd

NSE: BALPHARMA

Share Price

₹ 135.9

-0.95 (-0.69%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Bal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024135.9
21 Nov 2024136.85
19 Nov 2024131.05
18 Nov 2024125.65
14 Nov 2024119.7
13 Nov 2024114
12 Nov 2024118.9
11 Nov 2024120.65
08 Nov 2024125.8
07 Nov 2024126.1

SWOT Analysis Of Bal Pharma Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bal Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Bal Pharma Ltd

No data available

No data available

Historical P/E Ratio of Bal Pharma Ltd

No data available

* All values are in %

Historical Revenue of Bal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bal Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Bal Pharma Ltd

No data available

* All values are in

About Bal Pharma Ltd

  • Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87.
  • In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc.
  • The company promotes its products through the common sales force of the group but proposes to induct its own soon.
  • It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited.

Bal Pharma Ltd News Hub

News

Bal Pharma schedules board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 14 November 202...

Read more

06 Nov 202420:13

News

Bal Pharma to convene board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 9 September 202...

Read more

31 Aug 202410:27

News

Bal Pharma schedules AGM

Bal Pharma announced that the Annual General Meeting (AGM) of the company will be held on ...

Read more

16 Aug 202411:19

News

Bal Pharma schedules board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2024....

Read more

26 Jul 202416:28

News

Board of Bal Pharma recommends final dividend

Bal Pharma announced that the Board of Directors of the Company at its meeting held on 28 ...

Read more

29 May 202409:43

News

Bal Pharma Ltd leads gainers in 'B' group

Amines & Plasticizers Ltd, Jet Freight Logistics Ltd, Arrow Greentech Ltd and Emkay Global...

Read more

29 May 202412:15

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Bal Pharma Ltd Market Cap

What is the market cap of Bal Pharma Ltd?

As of November 24, 2024, Bal Pharma Ltd has a market capitalization of ₹216.36, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Bal Pharma Ltd's market capitalization?

Bal Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Bal Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Bal Pharma Ltd's market capitalization change?

Bal Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*